Nostrum Expands its Metformin HCl Extended Release Recall
FDA - According to an FDA Recall Update, Nostrum Laboratories, Inc. expended its nationwide recall of its Metformin HCl Extended-Release Tablets, USP 750 mg, on January 25, 2021. The reason for the recall is due to the unsafe, higher than Acceptable Daily Intake (ADI) amount of N-Nitrosodimethylamine (NDMA). The maximum allowable … [Read more...] about Nostrum Expands its Metformin HCl Extended Release Recall
The Number of Metformin Products Recalled Exploded in 2020
Metformin Lawsuits Seeking Monetary Compensation Due to Cancerous N-nitrosodimethylamine (NDMA) Contamination is Likely to Explode in 2021 and Beyond. THE UNITED STATES - According to a news report posted on medpagetoday.com, the total number of Metformin products recalled in 2020 grew substantially. The most recent list of … [Read more...] about The Number of Metformin Products Recalled Exploded in 2020
Granules Pharmaceuticals Metformin Hydrochloride NDMA Lawsuits
Granules Pharmaceuticals, Inc. Recalls its 750 mg Extended-Release Tablet of USP Metformin Hydrochloride (Metformin) Due to NDMA Carcinogen Contamination WASHINGTON, D.C. — The U.S. Food and Drug Administration, FDA, announced that the prescription drug maker Granules Pharmaceuticals, Inc. issued a voluntary recall for its 750 … [Read more...] about Granules Pharmaceuticals Metformin Hydrochloride NDMA Lawsuits
